Sequential multi-locus transcranial magnetic stimulation for treatment of obsessive-compulsive disorder with comorbid major depression: A case series by Tadayonnejad, Reza et al.
lable at ScienceDirect
Brain Stimulation xxx (xxxx) xxxContents lists avaiBrain Stimulation
journal homepage: http: / /www.journals .e lsevier .com/brain-st imulat ionSequential multi-locus transcranial magnetic stimulation for treatment
of obsessive-compulsive disorder with comorbid major depression: A
case seriesObsessive-compulsive disorder (OCD) andmajor depressive dis-
order (MDD) are highly comorbid [1], with depressive symptoms
amplifying the chronicity and severity of OCD symptoms. Comorbid
illness decreases quality of life and daily functioning [2] and is asso-
ciated with greater suicidality and more frequent inpatient hospi-
talizations [3]. Furthermore, comorbid OCD/depression is
associated with poorer response to OCD-focused psychological
and pharmacological treatments [4]. Epidemiologic studies have
shown that OCD symptoms generally precedes the occurrence of
depression, suggesting a causal interacting model in which OCD
predisposes to development of depressive symptoms [5]. In line
with that causal model, Tadayonnejad et al. showed aberrant effec-
tive (directional) connectivity between OCD and MDD circuits may
be a potential network mechanism of depressive symptom genesis
or worsening in OCD-MDD [6]. The challenging nature of this co-
morbidity necessitates the development of novel, more effective
treatments.
In this study, we tested an innovative multi-site repetitive
transcranial magnetic stimulation (rTMS) protocol to target OCD
and MDD circuits in seven patients with refractory comorbid
OCD-MDD (5 males, 2 females, mean age 35 ± 7.92, 6/7 on medi-
cations). Consent for treatment was obtained from all patients.
The UCLA Institutional Review Board approved this retrospective
analysis of de-identified data. Patients had high baseline OCD
(mean YaleeBrown Obsessive Compulsive scale [Y-BOCS] score
of 24.2 ± 3.15) and depressive symptoms (mean Inventory of
Depressive Symptomatology-Self-Report [IDS-SR] score of
45.1 ± 13.48). Before seeking TMS treatment, each patient had
tried 4e14 different psychotropic medications (average 6.8 ± 3.7
medications including SSRIs and antipsychotics) and 2e3 courses
of psychotherapy (average 2.4 ± 0.5 including cognitive behavior
therapy and/or exposure and response prevention), resulting in
a non-optimal improvement. The average duration of OCD and
MDD conditions across patients was 22 ± 5.8 years and 16 ± 4.6
years, respectively.
Patients received 36 rTMS sessions. Each session included 10 Hz
excitatory rTMS (3000 pulses) or intermittent theta burst stimula-
tion (iTBS; 600 pulses) over the left dorsolateral prefrontal cortex
(DLPFC) followed by 1200 pulses of 1Hz inhibitory rTMS over the
bilateral supplementary motor area (SMA). Motor threshold (MT)
for each patient was determined during session 1 and treatmenthttps://doi.org/10.1016/j.brs.2020.10.003
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the SMA as tolerated. Patients showed a robust therapeutic
response in both OCD (Y-BOCS on T36:12.71 ± 5.56; P ¼ 0.0013)
and depressive (IDS-SR on T36: 19.29 ± 7.13; P¼ 0.0017) symptoms.
Five out of seven patients showed full OCD response (35% reduc-
tion in Y-BOCS) and five patients showed full depression response
(50% reduction in IDS-SR scores). The two remaining patients
showed partial response of both OCD and MDD symptoms
(20e34% reduction in Y-BOCS, 30e50% reduction in IDS-SR scores)
(Fig. 1). There were no adverse events leading to treatment discon-
tinuation. All patients were treated during the past 1.5 years and
none has returned for retreatment, although systematic post-
treatment follow-up data are not available.
Therapeutic mechanisms of the DLPFC and SMA stimulation
may be understood in the context of interconnected circuits of
which those regions are important components. DLPFC is a part
of the Default Mode Network (DMN), which has been reported to
have aberrant function in both OCD and MDD [7,8]. The therapeutic
benefit of DLPFC stimulationmay bemediated through connections
to the subgenual [9] and pregenual [10] anterior cingulate cortex.
Interestingly, in Tadayonnejad et al. (2018) study, pregenual ante-
rior cingulate cortex was shown to mediate the abnormal interac-
tion between cortico-striatal-thalamo-cortical OCD and fronto-
limbic MDD circuits. We suggest that DLPFC TMS by modulating
pregenual anterior cingulate cortex function not only impacts
within (DMN) circuit dynamics but also between (OCD and MDD)
circuits interaction. Furthermore, we speculate that inhibitory
rTMS to the SMA by dampening the habit circuit (SMA-putamen)
provides its therapeutic effect by alleviating the urge to perform
habitual compulsions.
In comorbid psychiatric conditions like OCD-MDD, aberrant dy-
namics exist not only within but also between multiple intercon-
nected circuits. We suggest that targeting multiple brain regions
through an approach such as that described here is a good thera-
peutic strategy to normalize pathological dynamics within and be-
tween the involved circuits in OCD-MDD and other comorbid
psychiatric conditions. These preliminary results in this group of
highly treatment-resistant OCD-MDD patients are encouraging
and need to be replicated in prospective sham-controlled studies
with larger sample sizes.under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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Fig. 1. Graphs of depression (Blue) and OCD (Red) symptom severity decrease over the course of 36 sequential multi-locus TMS treatment sessions in 7 patients with refractory
comorbid OCD and in response to the left DLPFC (excitatory) and SMA (inhibitory) TMS (right); graph bars of average depression, total OCD and obsession and compulsion sub-
components of OCD symptom severity percent reduction (left). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this
article.)
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